Drug & intervention

valsartan 160 MG

RxCUI 316881

Clinical trials5

Recruiting1

Related conditions10

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

5 shown

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black IndividualsNCT04055428 · 2020-08-15

A Phase II Clinical Study of QR12000 Compound Tablets in Patients With Moderate to Severe Essential HypertensionNCT07700875 · 2022-12-29

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential HypertensionNCT01001572 · 2009-09-01

Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With HypertensionNCT00413413 · 2007-01-01

A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart FailureNCT00294086 · 2005-12-01

Conditions being studied

Essential Hypertension2 Cardiovascular Diseases1 Chronic Heart Failure1 Diabetes Mellitus1 Energy Expenditure1 Hypertension1 Insulin Sensitivity/Resistance1 Metabolic Disease1 Metabolism1 Natriuretic Peptides1

Research locations

BeijingChina1 BirminghamAlabama, United States1 HangzhouChina1 NanjingChina1 ShanghaiChina1

Leading sponsors

Novartis2 Novartis Pharmaceuticals1 University of Alabama at Birmingham1 Wuhan Createrna Science and Technology Co., Ltd1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.